Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Multicentre Randomized Double-blind Placebo Controlled Phase III Clinical Study to Assess Efficacy and Safety of Odelepran, 125 mg, for the Use in Patient With Alcohol Dependence

NCT03663374 is registered in ClinicalTrials.gov with R-Pharm as lead sponsor.

NCT NCT03663374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03663374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Multicentre Randomized Double-blind Placebo Controlled Phase III Clinical Study to Assess Efficacy and Safety of Odelepran, 125 mg, for the Use in Patient With Alcohol Dependence
Lead sponsor
R-Pharm
Phase
Phase 3
Overall status
Completed
Start date
November 18, 2014
Completion date
May 14, 2016
Enrollment
644 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence